Saturday, March 14, 2009

MIT Researchers Develop a Novel Drug-Delivery Gel


Shuguang Zhang, associate director of MIT's Center for Biomedical Engineering and his team have shown that a special gel may be used to deliver medications such as insulin, hormones, growth factors, or monoclonal antibodies like trastuzumab (Herceptin). The gel is being called a "nanofiber hydrogel scaffold." Wow, try explaining that to patients. This research was funded in part by the National Institutes of Health (NIH) and the High Q Foundation. The High Q Foundation, Inc. is a private philanthropic foundation that was established in 2002 with the mission of bringing together academia, industry, governmental agencies, and other funding organizations in the search for Huntington disease (HD) treatments.

No comments:

Post a Comment

Blog Widget by LinkWithin